Perrigo Company plc Extinguishment of Debt, Amount
Perrigo Company plc (PRGO) reported Extinguishment of Debt, Amount of $2.60 billion for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Debt
us-gaap:ExtinguishmentOfDebtAmount · last filed 2023-02-28
- Perrigo Company plc extinguishment of debt, amount for fiscal 2017 was $2.60B.
| Period end | Extinguishment of Debt, Amount | Extinguishment of Debt, Amount 12 month |
|---|---|---|
| 2017-12-31 | $2.60B 10-K · filed 2020-02-27 | |
| 2016-09-29 | $500.00M 10-K · filed 2023-02-28 | |
| 2016-09-26 | $500.00M 10-K · filed 2019-02-27 | |
| 2014-12-05 | $895.00M 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |